NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024

Nadeem R. Abu-Rustum; Catheryn M. Yashar; Rebecca Arend; Emma Barber; Kristin Bradley; Rebecca Brooks; Susana M. Campos; Junzo Chino; Hye Sook Chon; Marta Ann Crispens; Shari Damast; Christine M. Fisher; Peter Frederick; David K. Gaffney; Stephanie Gaillard; Robert Giuntoli; Scott Glaser; Jordan Holmes; Brooke E. Howitt; Jayanthi Lea; Gina Mantia-Smaldone; Andrea Mariani; David Mutch; Christa Nagel; Larissa Nekhlyudov; Mirna Podoll; Kerry Rodabaugh; Ritu Salani; John Schorge; Jean Siedel; Rachel Sisodia; Pamela Soliman; Stefanie Ueda; Renata Urban; Emily Wyse; Nicole R. McMillian; Shaili Aggarwal; Sara Espinosa

doi:10.6004/jnccn.2023.0062

NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024

Nadeem R. Abu-Rustum
, Catheryn M. Yashar
, Rebecca Arend
, Emma Barber
, Kristin Bradley
, Rebecca Brooks
, Susana M. Campos
, Junzo Chino
, Hye Sook Chon
, Marta Ann Crispens
, Shari Damast
, Christine M. Fisher
, Peter Frederick
, David K. Gaffney
, Stephanie Gaillard
, Robert Giuntoli
, Scott Glaser
, Jordan Holmes
, Brooke E. Howitt
, Jayanthi Lea

Gina Mantia-Smaldone, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Mirna Podoll, Kerry Rodabaugh, Ritu Salani, John Schorge, Jean Siedel, Rachel Sisodia, Pamela Soliman, Stefanie Ueda, Renata Urban, Emily Wyse, Nicole R. McMillian, Shaili Aggarwal, Sara Espinosa

Memorial Sloan-Kettering Cancer Center
University of California at San Diego
O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham
Northwestern University
University of Wisconsin-Madison
University of California at Davis
Dana-Farber/Brigham and Women's Cancer Center
Duke University
University of South Florida
Vanderbilt University
Yale University
University of Colorado Anschutz Medical Campus
University of Utah
University of Pennsylvania
City of Hope National Medical Center
Indiana University Bloomington
Stanford University
UT Southwestern Simmons Comprehensive Cancer Center
Fox Chase Cancer Center
Mayo Clinic
Washington University St. Louis
Ohio State University
University of Nebraska Medical Center
University of California at Los Angeles
St. Jude Children Research Hospital
University of Michigan, Ann Arbor
Mass General Cancer Center
University of Texas MD Anderson Cancer Center
University of California at San Francisco
Fred Hutchinson Cancer Research Center
Johns Hopkins University
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

355 Scopus citations

Abstract

The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

Original language	English
Pages (from-to)	1224-1233
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2023.0062
State	Published - Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Female
Humans
Uterine Cervical Neoplasms/diagnosis

Access to Document

10.6004/jnccn.2023.0062

Cite this

Abu-Rustum, N. R., Yashar, C. M., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Gaillard, S., Giuntoli, R., Glaser, S., Holmes, J., Howitt, B. E., ... Espinosa, S. (2023). NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024. JNCCN Journal of the National Comprehensive Cancer Network, 21(12), 1224-1233. https://doi.org/10.6004/jnccn.2023.0062

@article{c8169d7730dd41a3978eec6789c5c54a,

title = "NCCN GUIDELINES{\textregistered} INSIGHTS Cervical Cancer, Version 1.2024",

abstract = "The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.",

keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Humans, Uterine Cervical Neoplasms/diagnosis",

author = "Abu-Rustum, \{Nadeem R.\} and Yashar, \{Catheryn M.\} and Rebecca Arend and Emma Barber and Kristin Bradley and Rebecca Brooks and Campos, \{Susana M.\} and Junzo Chino and Chon, \{Hye Sook\} and Crispens, \{Marta Ann\} and Shari Damast and Fisher, \{Christine M.\} and Peter Frederick and Gaffney, \{David K.\} and Stephanie Gaillard and Robert Giuntoli and Scott Glaser and Jordan Holmes and Howitt, \{Brooke E.\} and Jayanthi Lea and Gina Mantia-Smaldone and Andrea Mariani and David Mutch and Christa Nagel and Larissa Nekhlyudov and Mirna Podoll and Kerry Rodabaugh and Ritu Salani and John Schorge and Jean Siedel and Rachel Sisodia and Pamela Soliman and Stefanie Ueda and Renata Urban and Emily Wyse and McMillian, \{Nicole R.\} and Shaili Aggarwal and Sara Espinosa",

year = "2023",

month = dec,

doi = "10.6004/jnccn.2023.0062",

language = "English",

volume = "21",

pages = "1224--1233",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "12",

}

Abu-Rustum, NR, Yashar, CM, Arend, R, Barber, E, Bradley, K, Brooks, R, Campos, SM, Chino, J, Chon, HS, Crispens, MA, Damast, S, Fisher, CM, Frederick, P, Gaffney, DK, Gaillard, S, Giuntoli, R, Glaser, S, Holmes, J, Howitt, BE, Lea, J, Mantia-Smaldone, G, Mariani, A, Mutch, D, Nagel, C, Nekhlyudov, L, Podoll, M, Rodabaugh, K, Salani, R, Schorge, J, Siedel, J, Sisodia, R, Soliman, P, Ueda, S, Urban, R, Wyse, E, McMillian, NR, Aggarwal, S & Espinosa, S 2023, 'NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 12, pp. 1224-1233. https://doi.org/10.6004/jnccn.2023.0062

TY - JOUR

T1 - NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024

AU - Abu-Rustum, Nadeem R.

AU - Yashar, Catheryn M.

AU - Arend, Rebecca

AU - Barber, Emma

AU - Bradley, Kristin

AU - Brooks, Rebecca

AU - Campos, Susana M.

AU - Chino, Junzo

AU - Chon, Hye Sook

AU - Crispens, Marta Ann

AU - Damast, Shari

AU - Fisher, Christine M.

AU - Frederick, Peter

AU - Gaffney, David K.

AU - Gaillard, Stephanie

AU - Giuntoli, Robert

AU - Glaser, Scott

AU - Holmes, Jordan

AU - Howitt, Brooke E.

AU - Lea, Jayanthi

AU - Mantia-Smaldone, Gina

AU - Mariani, Andrea

AU - Mutch, David

AU - Nagel, Christa

AU - Nekhlyudov, Larissa

AU - Podoll, Mirna

AU - Rodabaugh, Kerry

AU - Salani, Ritu

AU - Schorge, John

AU - Siedel, Jean

AU - Sisodia, Rachel

AU - Soliman, Pamela

AU - Ueda, Stefanie

AU - Urban, Renata

AU - Wyse, Emily

AU - McMillian, Nicole R.

AU - Aggarwal, Shaili

AU - Espinosa, Sara

PY - 2023/12

Y1 - 2023/12

N2 - The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

AB - The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Female

KW - Humans

KW - Uterine Cervical Neoplasms/diagnosis

UR - https://www.scopus.com/pages/publications/85179649106

U2 - 10.6004/jnccn.2023.0062

DO - 10.6004/jnccn.2023.0062

M3 - Article

C2 - 38081139

AN - SCOPUS:85179649106

SN - 1540-1405

VL - 21

SP - 1224

EP - 1233

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 12

ER -

NCCN GUIDELINES® INSIGHTS Cervical Cancer, Version 1.2024

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this